Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    23494214 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Immunogenicity and Safety Study of GSK Biologicals' Meningococcal Vaccine Given as One Dose to Healthy Subjects Above 56 Years
Condition: Meningococcal Serogroups A, C, W, or Y Infections
Interventions: Biological: Meningococcal vaccine GSK 134612;   Biological: MencevaxACWY TM

Indicates status has not been verified in more than two years